Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Amortization of Deferred Charges (2014 - 2023)

Mesoblast's (MEOBF) quarterly Amortization of Deferred Charges came in at $4.5 million in Q2 2023, up 2.3% year-over-year from $4.4 million in Q2 2022, and down 10.69% quarter-over-quarter from $5.0 million in Q1 2023.

Analysis

Mesoblast (MEOBF) Amortization of Deferred Charges (2014 - 2023) Analysis & Trends

Mesoblast has disclosed Amortization of Deferred Charges across 9 years of filings, most recently posting $4.5 million for Q2 2023.

  • In Q2 2023, Amortization of Deferred Charges rose 2.3% year-over-year to $4.5 million; the TTM figure through Jun 2023 stood at $20.1 million (up 16.39% YoY), while the FY2026 annual figure was $23.7 million, up 3.53% from the prior year.
  • Amortization of Deferred Charges came in at $4.5 million for Q2 2023 at Mesoblast, down from $5.0 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $6.1 million in Q4 2022 to a low of $2.2 million in Q3 2019.
  • Average Amortization of Deferred Charges over 5 years is $4.2 million, with a median of $4.4 million recorded in 2022.
  • Year-over-year, Amortization of Deferred Charges jumped 63.38% in 2021 and rose 2.3% in 2023.
  • Over 5 years, Amortization of Deferred Charges stood at $2.2 million in 2019, then grew by 17.04% to $2.5 million in 2020, then surged by 93.37% to $4.9 million in 2021, then advanced by 25.18% to $6.1 million in 2022, then fell by 27.42% to $4.5 million in 2023.
  • Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $4.5 million in Q2 2023, $5.0 million in Q1 2023, and $6.1 million in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn
10 Mesoblast 246.02 Mn 143.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 4.45 Mn
Mar 31, 2023 4.99 Mn
Dec 31, 2022 6.13 Mn
Sep 30, 2022 4.55 Mn
Jun 30, 2022 4.35 Mn
Mar 31, 2022 3.90 Mn
Dec 31, 2021 4.90 Mn
Sep 30, 2021 4.14 Mn
Sep 30, 2020 2.53 Mn
Sep 30, 2019 2.17 Mn
Sep 30, 2018 1.76 Mn
Dec 31, 2016 614,000.00
Sep 30, 2016 1.04 Mn
Jun 30, 2016 1.77 Mn
Dec 31, 2015 2.03 Mn
Sep 30, 2015 2.42 Mn
Jun 30, 2015 1.34 Mn
Sep 30, 2014 1.94 Mn